Starting on:
May 27, 2021
Ending on:
May 27, 2021
Moderator(s):
Venue:
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
May 27, 2021
Ending on:
May 27, 2021
Moderator(s):
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
JOURNAL CLUB - 27/05/2021
Starting on:
May 27, 2021 8:00 AM
May 27, 2021 8:00 AM
Ending on:
May 27, 2021 9:30 AM
May 27, 2021 9:30 AM
Venue:
THE KAREN HOSPITAL
THE KAREN HOSPITAL
Description
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
Objectives
- To examine the effects of the β1-blocker controlled-release/extended-release metoprolol succinate (metoprolol CR/XL) on mortality, hospitalization, symptoms, and quality of life in patients with heart failure.
- In this study of patients with symptomatic heart failure, metoprolol CR/XL improved survival, reduced the need for hospitalizations due to worsening heart failure, improved NYHA functional class, and had beneficial effects on patient well-being.
- The discovery of the pathophysiological importance of neuroendocrine activation in heart failure and the possibility of modifying such mechanisms of the disease process have greatly improved treatment in clinical practice.
Presenters
-
Dr.
ERICA CIMPAYE
MEDICAL OFFICER
The Karen Hospital